
Improved ex-vivo expansion of immune cells for use in cell therapy

Researchers from Goethe University Frankfurt developed a new method to increase proliferation and viability of immune cells, e.g. natural killer (NK) cells, derived from patients or donors. The obtained NK cell preparations are currently further evaluated for treatment of leukemia patients.
Further information: PDF
INNOVECTIS Gesellschaft für Innovations-Dienstleistungen mbH
Phone: +49 (0)69/2561632-0
Contact
Dr. Otmar Schöller
As Germany's association of technology- and patenttransfer agencies TechnologieAllianz e.V. is offering businesses access to the entire range of innovative research results of almost all German universities and numerous non-university research institutions. More than 2000 technology offers of 14 branches are beeing made accessable to businesses in order to assure your advance on the market. At www.technologieallianz.de a free, fast and non-bureaucratic access to all further offers of the German research landscape is offered to our members aiming to sucessfully transfer technologies.